Overview

Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19

Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This study is a pilot randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of melatonin in adult outpatients suspected to be afflicted with COVID-19.
Phase:
Phase 2
Details
Lead Sponsor:
State University of New York at Buffalo
Treatments:
Melatonin